» Articles » PMID: 31336496

The Association Between 25-hydroxy Vitamin D Deficiency and Diabetic Complications in Patients with Type 2 Diabetes Mellitus

Overview
Specialty Endocrinology
Date 2019 Jul 25
PMID 31336496
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To evaluation the relationship between serum 25-hydroxy vitamin D [25-(OH)D] deficiency and diabetic complications in patients with type 2 diabetes (T2DM).

Methods: One hundred and sixty three patients with T2DM [DM + uncomplicated (n = 36), DM + nephropathy (n = 31), DM + neuropathy (n = 30), DM + retinopathy (n = 30), DM + cardiovascular disease (CAD) (n = 36)], 35 CAD and 40 healthy volunteers were included.

Results: Serum 25-(OH)D levels were found as significantly lower in all patients compared to the control group (p < 0.05). 25-(OH)D in patients with DM + retinopathy (p < 0.006), DM + nephropathy (p < 0.001) and DM + neuropathy (p < 0.001) was significantly lower than that of the control group. 25-(OH)D in patients with DM + nephropathy (p < 0.001), DM + neuropathy (p < 0.01) and DM + retinopathy (p < 0.001) was significantly lower than in the DM + uncomplicated group. 25-(OH)D levels were found as significantly lower in DM + CAD compared to the CAD group (p < 0.01). Serum 25-(OH)D and HbA1c and parathyroid hormone (PTH) were found to be negatively correlated with each other in DM + all complications.

Conclusions: Low serum 25-OHD levels were found to be associated with the development of diabetes and complications. Low serum 25-OHD levels may be a consequence of even worse metabolic control of diabetes.

Citing Articles

Predictive value of bone metabolism markers in the progression of diabetic kidney disease: a cross-sectional study.

Kang Y, Jin Q, Zhou M, Li Z, Zheng H, Li D Front Endocrinol (Lausanne). 2024; 15:1489676.

PMID: 39558979 PMC: 11570274. DOI: 10.3389/fendo.2024.1489676.


Relationship between bone turnover markers and renal disease in elderly patients with type 2 diabetes: a cross-sectional study.

Wei S, Pan X, Wei J BMC Endocr Disord. 2024; 24(1):179.

PMID: 39237970 PMC: 11378410. DOI: 10.1186/s12902-024-01698-y.


Nutritional Strategies against Diabetic Nephropathy: Insights from Animal Studies and Human Trials.

Zhou J, Franceschini N, Townley-Tilson W, Maeda-Smithies N Nutrients. 2024; 16(12).

PMID: 38931271 PMC: 11206721. DOI: 10.3390/nu16121918.


Are There Any Pleiotropic Benefits of Vitamin D in Patients With Diabetic Kidney Disease? A Systematic Review of Randomized Controlled Trials.

Sharma J, Khan S, Wilson T, Pilkey N, Kapuria S, Roy A Can J Kidney Health Dis. 2023; 10:20543581231212039.

PMID: 38033482 PMC: 10683388. DOI: 10.1177/20543581231212039.


Progression of diabetic nephropathy and vitamin D serum levels: A pooled analysis of 7722 patients.

Dean Y, Elawady S, Shi W, Salem A, Chotwatanapong A, Ashraf H Endocrinol Diabetes Metab. 2023; 6(6):e453.

PMID: 37743677 PMC: 10638614. DOI: 10.1002/edm2.453.